ATM/p53-p21 cross-regulatory network may play a crucial role in mediating the anticarcinogenic activities of genistein in colon cancer. »
11/16/12

Expression patterns of CTAs and NY-BR-1 in breast cancer and their correlation to clinico-pathological parameters in order to determine their possible impact as prognostic factors. »
06/03/13

MicroRNA biomarkers in glioblastoma. »
01/03/13

miRNA analysis in urine appears to be a valuable tool for the non-invasive assessment of UCC. »
01/24/13

Pfn1 has a dichotomous role in early vs late steps of breast cancer metastasis. »
05/20/13

Critical role for intracellular signaling pathways downstream of the ShcA PTB domain in breast cancer progression. »
05/23/13

Activation of NFkB is a novel mechanism of pro-survival activity of glucocorticoids in breast cancer cells. »
01/09/13

Targeting PI3K/AKT pathway or inhibiting HSP70 expression may be beneficial for chemotherapy treatment of Burkitt lymphoma patients. »
05/24/13

Relationship between TGF-beta1 expression and clinicopathological microinvasion in patients with small lung adenocarcinoma. »
05/25/13

Epidermal growth factor receptor (EGFR) is a member of the receptor tyrosine kinase (RTK) family. Epidermal growth factor induces its dimerization and stimulates phosphorylation of intracellular tyrosine residues. Phosphorylation of EGFR is studied for cancer therapy because EGFR regulates many cellular processes including cell proliferation, differentiation, and survival. Hence, down-regulation of EGFR kinase activity results in inhibition of signaling cascades amenable for proliferation and progression of cell cycle. »
05/25/13